PUBLIC CONTRACT · 2019
4180261/2019 - Antitripsina alfa-1 1000 mg (50 mg/ml AMP 20ML) po sol inj (respreeza)
- Contract value
- €8,581.76
- Signed on
- 24 May 2019
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 5739563PUBLISHED SUBJECT
4180261/2019 - ANTITRIPSINA ALFA-1 1000 MG (50 MG/ML AMP 20ML) PO SOL INJ (RESPREEZA)
Parties involved
- Place of performance
- Portugal, Setúbal, Barreiro
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- C S L BEHRING UNIPESSOAL,LDA. · Tax ID 503047201
Values and timeline
- Contract price
- €8,581.76
- Procedure base price
- €8,581.76
- Total effective price
- €8,581.76
- Publication date
- 30 July 2019
- Award date
- 24 May 2019
- Signing date
- 24 May 2019
- Performance period
- 30 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Melhor relação qualidade – preço
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL 111-B/2017 ) e DLR no 34/2008/M, de 14.08 (DLR n.º 6/2018/M)
- Framework agreement
- ACORDO QUADRO PARA FORNECIMENTO DE FACTORES VIII E IX DA COAGULAÇÃO HUMANA, FACTOR VIII DA COAGULAÇÃO HUMANA + FACTOR DE VON WILLEBRAND HUMANO E FACTOR DE VON WILLEBRAND HUMANO ÀS INSTITUIÇÕES E SERVIÇOS DO SERVIÇO NACIONAL DE SAÚDE CP 2015/9A
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 4120357
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.